Mechanism for Time-Sensitive Substance Use Research (R21 Clinical Trial Optional)
This grant supports urgent research on substance use epidemics and trends, focusing on responses to sudden spikes and emerging issues in drug abuse and health care services.
This grant is no longer accepting proposals
National Institutes of Health has archived this opportunity.
Funder: National Institutes of Health
Due Dates: March 5, 2025 (Open Date) | May 5, 2025 | September 9, 2025 | January 12, 2026 | March 11, 2026 (Expiration/Final Deadline)
Funding Amounts: Up to $275,000 direct costs over 2 years; no more than $200,000 in any single year.
Summary: Supports rapid, time-sensitive pilot or exploratory research in substance use epidemiology, health services, and related policy or system changes.
Key Information: Applications must justify the need for accelerated review due to time-sensitive research opportunities.
Description
This funding opportunity supports pilot, feasibility, or exploratory research in priority areas of substance use epidemiology and health services. It is specifically designed to address urgent, time-sensitive research questions that arise from sudden or severe drug issues, emerging trends (such as changes in marijuana or prescription drug use), shifts in policy, medical system changes, or criminal/juvenile justice system developments. Projects must clearly demonstrate the necessity for expedited review and funding, such as imminent policy changes or acute public health events, where standard NIH review cycles would not suffice. The mechanism encourages collaborations between researchers and community or public partners facing urgent substance-related health crises.
